2019•Iraqi Journal of BiotechnologyRequires access

Review: Hormonal Disturbance in Ambiguous Patients

Rand Arkan Abd-AL Kareem, Abdul Hussein Moyet Al-Faisal

Open publisher page 0 citations

Abstract

Sex development in humans is divided into two sequential steps: sex determination and sex differentiation. Sex determination refers to the expression of gene networks that direct the development of undifferentiated bipotential gonads into either testes or ovaries. Once developed, testes and ovaries secrete hormones that promote further sex differentiation of the body throughout embryonic development and adulthood. Mutations have been identified in genes that control both steps, leading to Disorders of sex development-DSD. A thorough history, physical examination, and appropriate diagnostic testing are needed to identify the underlying etiology. DSD are congenital conditions in which development of chromosomal, gonadal, or anatomic sex is atypical. DSD are chronic medical conditions collectively affecting ~1% of the population, frequently requiring life-long care by multiple specialists, and carrying a significant public health burden. Some of DSD are associated with life-threatening events, such as adrenal crises in congenital adrenal hyperplasia. DSD are also associated with increased infertility, cancer, gender dysphoria risks, psychosocial distress, and pervasive challenges to health-related quality of life for patients and families. DSD are broadly classified into three categories: sex chromosome DSD, 46, XY DSD, and 46, XX DSD and are further classified according to the type of gonad found in the patient (ovary, testis, ovotestis). Currently, known etiologies include disorders of gonadal development and disorders in androgen synthesis or action, and are considered Mendelian. Ambiguous genitalia is defined as a condition in which there is difficulty in assigning sex of an individual based on the appearance of external genitalia. Possible genital presentations are: male or female regular, males with ambiguous features and hypovirilization (micropenis, lack of scrotal fusion, incomplete testicular descent, hypospadia) or females with ambiguous features and virilization (clitoromegaly, labio-scrotal fusion).

About this research paper

What this paper is about

Sex development in humans is divided into two sequential steps: sex determination and sex differentiation. Sex determination refers to the expression of gene networks that direct the development of undifferentiated bipotential gonads into either testes or ovaries. Once developed, testes and ovaries secrete hormones that promote further sex differentiation of the body throughout embryonic development and adulthood. Mutations have been identified in genes that control both steps, leading to Disorders of sex development-DSD. A thorough history, physical examination, and appropriate diagnostic testing are needed to identify the underlying etiology. DSD are congenital conditions in which development of chromosomal, gonadal, or anatomic sex is atypical. DSD are chronic medical conditions collectively affecting ~1% of the population, frequently requiring life-long care by multiple specialists, and carrying a significant public health burden. Some of DSD are associated with life-threatening events, such as adrenal crises in congenital adrenal hyperplasia. DSD are also associated with increased infertility, cancer, gender dysphoria risks, psychosocial distress, and pervasive challenges to health-related quality of life for patients and families. DSD are broadly classified into three categories: sex chromosome DSD, 46, XY DSD, and 46, XX DSD and are further classified according to the type of gonad found in the patient (ovary, testis, ovotestis). Currently, known etiologies include disorders of gonadal development and disorders in androgen synthesis or action, and are considered Mendelian. Ambiguous genitalia is defined as a condition in which there is difficulty in assigning sex of an individual based on the appearance of external genitalia. Possible genital presentations are: male or female regular, males with ambiguous features and hypovirilization (micropenis, lack of scrotal fusion, incomplete testicular descent, hypospadia) or females with ambiguous features and virilization (clitoromegaly, labio-scrotal fusion).

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Sex development in humans is divided into two sequential steps: sex determination and sex differentiation. Sex determination refers to the expression of gene networks that direct the development of undifferentiated bipotential gonads into either testes or ovaries. Once developed, testes and ovaries secrete hormones that promote further sex differentiation of the body throughout embryonic development and adulthood. Mutations have been identified in genes that control both steps, leading to Disorders of sex development-DSD. A thorough history, physical examination, and appropriate diagnostic testing are needed to identify the underlying etiology. DSD are congenital conditions in which development of chromosomal, gonadal, or anatomic sex is atypical. DSD are chronic medical conditions collectively affecting ~1% of the population, frequently requiring life-long care by multiple specialists, and carrying a significant public health burden. Some of DSD are associated with life-threatening events, such as adrenal crises in congenital adrenal hyperplasia. DSD are also associated with increased infertility, cancer, gender dysphoria risks, psychosocial distress, and pervasive challenges to health-related quality of life for patients and families. DSD are broadly classified into three categories: sex chromosome DSD, 46, XY DSD, and 46, XX DSD and are further classified according to the type of gonad found in the patient (ovary, testis, ovotestis). Currently, known etiologies include disorders of gonadal development and disorders in androgen synthesis or action, and are considered Mendelian. Ambiguous genitalia is defined as a condition in which there is difficulty in assigning sex of an individual based on the appearance of external genitalia. Possible genital presentations are: male or female regular, males with ambiguous features and hypovirilization (micropenis, lack of scrotal fusion, incomplete testicular descent, hypospadia) or females with ambiguous features and virilization (clitoromegaly, labio-scrotal fusion).

Key concepts: Disorders of sex development, Testis determining factor, Ovotestis, Congenital adrenal hyperplasia, Sexual differentiation, Gonad, Feminization (sociology), Population

Related papers

Back to paper searchBrowse research topicsOriginal source
Review: Hormonal Disturbance in Ambiguous Patients — Research Paper | ScholarLens